These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18249540)

  • 1. 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability.
    Moorjani M; Zhang X; Chen Y; Lin E; Rueter JK; Gross RS; Lanier MC; Tellew JE; Williams JP; Lechner SM; Malany S; Santos M; Ekhlassi P; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J; Slee DH
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1269-73. PubMed ID: 18249540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stability.
    Moorjani M; Luo Z; Lin E; Vong BG; Chen Y; Zhang X; Rueter JK; Gross RS; Lanier MC; Tellew JE; Williams JP; Lechner SM; Malany S; Santos M; Crespo MI; Díaz JL; Saunders J; Slee DH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5402-5. PubMed ID: 18835161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
    Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X
    Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the field of A2A and A3 adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Bovero A; Avitabile B; Preti D; Fruttarolo F; Romagnoli R; Varani K; Borea PA
    Eur J Med Chem; 2003 Apr; 38(4):367-82. PubMed ID: 12750024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of molecular modeling aided design to dial out hERG liability in adenosine A(2A) receptor antagonists.
    Deng Q; Lim YH; Anand R; Yu Y; Kim JH; Zhou W; Zheng J; Tempest P; Levorse D; Zhang X; Greene S; Mullins D; Culberson C; Sherborne B; Parker EM; Stamford A; Ali A
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2958-62. PubMed ID: 26048804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
    Neustadt BR; Liu H; Hao J; Greenlee WJ; Stamford AW; Foster C; Arik L; Lachowicz J; Zhang H; Bertorelli R; Fredduzzi S; Varty G; Cohen-Williams M; Ng K
    Bioorg Med Chem Lett; 2009 Feb; 19(3):967-71. PubMed ID: 19109019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists.
    Zhang X; Rueter JK; Chen Y; Moorjani M; Lanier MC; Lin E; Gross RS; Tellew JE; Williams JP; Lechner SM; Markison S; Joswig T; Malany S; Santos M; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J; Slee DH
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1778-83. PubMed ID: 18329269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2.
    Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Higgins GA; Cohen-Williams ME; Varty GB; Tulshian DB
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3675-8. PubMed ID: 15982882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of N-substituted 2-amino-4,5-diarylpyrimidines as selective adenosine A
    Alachouzos G; Lenselink EB; Mulder-Krieger T; de Vries H; IJzerman AP; Louvel J
    Eur J Med Chem; 2017 Jan; 125():586-602. PubMed ID: 27718474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.
    Slee DH; Moorjani M; Zhang X; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Jalali K; Sai Y; Zuo Z; Yang C; Wen J; O'Brien Z; Petroski R; Saunders J
    J Med Chem; 2008 Mar; 51(6):1730-9. PubMed ID: 18307293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
    Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
    Gillespie RJ; Bamford SJ; Botting R; Comer M; Denny S; Gaur S; Griffin M; Jordan AM; Knight AR; Lerpiniere J; Leonardi S; Lightowler S; McAteer S; Merrett A; Misra A; Padfield A; Reece M; Saadi M; Selwood DL; Stratton GC; Surry D; Todd R; Tong X; Ruston V; Upton R; Weiss SM
    J Med Chem; 2009 Jan; 52(1):33-47. PubMed ID: 19072055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a New Series of Potent Adenosine A
    Yang Z; Li L; Zheng J; Ma H; Tian S; Li J; Zhang H; Zhen X; Zhang X
    ACS Chem Neurosci; 2016 Nov; 7(11):1575-1584. PubMed ID: 27569066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
    Hodgson RA; Bertorelli R; Varty GB; Lachowicz JE; Forlani A; Fredduzzi S; Cohen-Williams ME; Higgins GA; Impagnatiello F; Nicolussi E; Parra LE; Foster C; Zhai Y; Neustadt BR; Stamford AW; Parker EM; Reggiani A; Hunter JC
    J Pharmacol Exp Ther; 2009 Jul; 330(1):294-303. PubMed ID: 19332567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Aminopyrimidines as dual adenosine A1/A2A antagonists.
    Robinson SJ; Petzer JP; Terre'Blanche G; Petzer A; van der Walt MM; Bergh JJ; Lourens AC
    Eur J Med Chem; 2015 Nov; 104():177-88. PubMed ID: 26462195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
    Kiselgof E; Tulshian DB; Arik L; Zhang H; Fawzi A
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2119-22. PubMed ID: 15808481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists.
    Luthra PM; Mishra CB; Jha PK; Barodia SK
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1214-8. PubMed ID: 20018509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
    Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.